Starling Oncology Wt's current assets is $130M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), STLNW shows a current assets of $130M. That compares with $100M in the prior-year period — up 23.1% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, STLNW's current assets is now $130M (was $100M) — a 23.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Starling Oncology Wt is outperforming or lagging.
Tracking STLNW's current assets over time shows whether Starling Oncology Wt is scaling, shrinking, or reshaping that part of the business. The current reading is $130M That compares with $100M in the prior-year period — up 23.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current assets page, Stockcircle has Starling Oncology Wt's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $130M) with ownership activity and broader fundamentals.